tradingkey.logo
tradingkey.logo
Buscar

Progyny Inc

PGNY
Añadir a la lista de seguimiento
29.450USD
+0.620+2.15%
Cierre 07/01, 16:00ETCotizaciones retrasadas 15 min
2.31BCap. mercado
36.51P/E TTM

Más Datos de Progyny Inc Compañía

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Información de Progyny Inc

Símbolo de cotizaciónPGNY
Nombre de la empresaProgyny Inc
Fecha de salida a bolsaOct 25, 2019
Director ejecutivoAnevski (Peter)
Número de empleados675
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 25
Dirección1359 Broadway
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10018
Teléfono12128883124
Sitio Webhttps://www.progyny.com/
Símbolo de cotizaciónPGNY
Fecha de salida a bolsaOct 25, 2019
Director ejecutivoAnevski (Peter)

Ejecutivos de Progyny Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
11.27K
-10.95%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
5.38K
-15.24%
Mr. David Schlanger
Mr. David Schlanger
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Norman C. Payson, M.D.
Dr. Norman C. Payson, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
617.11K
-0.87%
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
30.62K
+25.88%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
20.70K
+32.81%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
19.99K
-14.07%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
18.49K
+36.73%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
13.08K
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Progyny Inc?

Los cinco principales accionistas de Progyny Inc son: Mr. Peter (Pete) Anevski

¿Cuántas instituciones poseen acciones de Progyny Inc (PGNY)?

A fecha de 2026Q1, 790 instituciones poseen acciones de Progyny Inc, con un valor de mercado combinado de aproximadamente 88.51M, lo que representa el 113.05% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -31976779.00.

¿Cuál es la mayor fuente de ganancias de Progyny Inc?

El 2026Q1, el segmento empresarial Fertility benefits services revenue generó la ganancia más alta para Progyny Inc, ascendiendo a 830.93M y representando el 64.48% de la ganancia total.